[1]于红梅,史晴晴,陈颖,等.rt-PA溶栓时机对急性缺血性脑卒中伴心房颤动患者的溶栓效果及安全性的影响[J].卒中与神经疾病杂志,2018,25(05):521-524.[doi:10.3969/j.issn.1007-0478.2018.05.007]
　Yu Hongmei,Shi Qingqing,Chen Ying,et al.The influence of thrombolytic timing of rt-PA on thrombolytic effect and safety of patients with acute ischemic stroke combined with atrial fibrillation[J].Stroke and Nervous Diseases,2018,25(05):521-524.[doi:10.3969/j.issn.1007-0478.2018.05.007]
点击复制

rt-PA溶栓时机对急性缺血性脑卒中伴心房颤动患者的溶栓效果及安全性的影响()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第25卷
期数:
2018年05期
页码:
521-524
栏目:
论 著
出版日期:
2018-10-26

文章信息/Info

Title:
The influence of thrombolytic timing of rt-PA on thrombolytic effect and safety of patients with acute ischemic stroke combined with atrial fibrillation
文章编号:
1007-0478(2018)05-0521-04
作者:
于红梅; 史晴晴; 陈颖; 张洁
065700 河北省廊坊市第四人民医院神经内科
Author(s):
Yu Hongmei; Shi Qingqing; Chen Ying; et al.
Department of Neurology,Hebei Province Langfang City Fourth People's Hospital,Langfang Hebei 065700
关键词:
rt-PA 急性缺血性脑卒中 心房颤动 溶栓时机
Keywords:
rt-PA Acute cerebral infarction Atrial fibrillation Treatment timing
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2018.05.007
文献标志码:
A
摘要:
目的 探讨rt-PA溶栓时机对急性缺血性脑卒中伴心房颤动患者的溶栓效果及安全性的影响。方法 选取本院2015年4月-2017年8月收治急性缺血性脑卒中伴心房颤动患者共124例,其中发病后3～4.5 h行rt-PA溶栓共64例设为对照组,发病后3 h内行rt-PA溶栓共60例设为观察组; 比较2组患者溶栓有效率、治疗前后NIHSS评分、随访mRS评分及严重出血事件发生率。结果 观察组患者溶栓有效率显著高于对照组(P<0.05); 2组患者治疗后1和7d NIHSS评分均显著低于治疗前(P<0.05); 观察组患者治疗后1 d NIHSS评分显著低于对照组(P<0.05); 2组患者治疗后7d NIHSS评分比较差异无显著性(P>0.05); 2组患者随访mRS评分分级情况比较差异无显著性(P>0.05); 2组患者出血性脑梗死和脑部症状性出血发生率比较差异无显著性(P>0.05); 观察组患者治疗后脑实质出血发生率显著低于对照组(P<0.05)。结论 急性缺血性脑卒中伴心房颤动患者在发病后3 h内行rt-PA溶栓在可提高溶栓效果和促进受损神经功能恢复方面较发病后3～4.5 h溶栓具有明显优势,但在远期疗效和严重出血事件发生风险方面两者接近。
Abstract:
ObjectiveTo investigate the influence of thrombolytic timing of rt-PA on thrombolytic effect and safety of patients with acute ischemic stroke combined with atrial fibrillation.Methods 124 patients with acute cerebral infarction combined with atrial fibrillatio were chosen in the period from April 2015 to August 2017 in our hospital and divided into both group according to treatment timing,control group(64 patients)were treated with rt-PA for 3～4.5 h after morbidity and observation group(60 patients)were treated with rt-PA for <3 h after morbidity,and the thrombolysis effective rate after operation,NIHSS scores before and after treatment,mRS scores with follow-up and serious bleeding events incidence of both groups were compared.Results The thrombolysis effective rate of observation group after thrombolytic treatment was significantly higher than that of control group(P<0.05).The NIHSS scores in 1 d and 7 d after treatment of both groups were significantly lower than those before treatment(P<0.05).The NIHSS scores of observation group in 1 d after treatment were significantly lower than those of control group(P<0.05).There was no significant difference in the NIHSS scores in 7 d after treatment between 2 groups(P>0.05)There was no significant difference in the mRS scores with follow-up between 2 groups(P>0.05).There was no significant difference in the incidence of hemorrhagic infarction and symptomatic intracerebral hemorrhage between 2 groups(P>0.05).The incidence of cerebral parenchyma hemorrhage of observation group was significantly lower than that of control group(P<0.05).Conclusion Compared with rt-PA for 3～4.5 h,rt-PA for <3 h after morbidity in the treatment of patients with acute cerebral infarction combined with atrial fibrillation possessed the advantages including higher the thrombolytic effects and promoted the damaged nerve function recovery and had the same in the clinical effects for long term and the bleeding events risk.

参考文献/References:

[1] Adeoye O,Knight WA,Khoury J,et al.A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke[J].J Stroke Cerebrovasc Dis,2014,23(5):e313-e315.
[2] Andersson T,Magnuson A,Bryngelsson IL,et al.Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score,age and sex - A Swedish nationwide observational study with 48 433 patients[J].PLoS One,2017,12(5):e0176846.
[3] Wen WB,Cheng,Dong,et al.Relationship between abnormal vagus nerve tension and basal ganglia cerebral infarction induced paroxysmal atrial fibrillation[J].Asian Pac J Trop Med,2017,10(9):921-924.
[4] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华医学信息导报,2010,25(14):16-19.
[5] Zaw KTT,Sato N,Ikeda S,et al.Association of ZFHX3 gene variation with atrial fibrillation,cerebral infarction,and lung thromboembolism:An autopsy study[J].J Cardiol,2017,70(2):180-184.
[6] Kim WJ,Park JM,Kang K,et al.Adherence to guidelines for antithrombotic therapy in patients with atrial fibrillation according to CHADS2 score before and after stroke:a multicenter observational study from Korea[J].J Clin Neurol,2016,12(1):34-41.
[7] Sandhu RK,Ezekowitz J,Andersson U,et al.The 'obesity paradox' in atrial fibrillation:observations from the Aristotle(Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)trial[J].Eur Heart J,2016,37(38):2869-2878.
[8] Groot JD,Ruff CT,Murphy SA,et al.5719Edoxaban versus warfarin in patients with atrial fibrillation in relation to stroke risk.A subanalysis of the ENGAGE AF-TIMI 48 study[J].Euro Heart J,2017,38(suppl 1):1027-1033.
[9] Kamel H,Okin PM,Elkind MS,et al.Atrial fibrillation and mechanisms of stroke:time for a new model[J].Stroke,2016,47(3):895-900.
[10] Kunisawa S,Kobayashi D,Lee J,et al.Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke[J].Journal of Stroke & Cerebrovascular Diseases,2014,23(4):724-731.
[11] Yang X,Li Z,Zhao X,et al.Use of warfarin at discharge among acute ischemic stroke patients with nonvalvular atrial fibrillation in China[J].Stroke,2016,47(2):464-470.
[12] Hsu JC,Maddox TM,Kennedy K,et al.Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke[J].J Am Coll Cardiol,2016,67(25):2913-2923.
[13] Stone NJ,Robinson JG,Lichtenstein AH,et al.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults a report of the American college of cardiology/American heart association task force on practice guidelines[J].J Am Coll Cardiol,2014,63(25,B):2889-2934.
[14] Shirokane K,Umeoka K,Mishina M,et al.Hemothorax after the intravenous administration of tissue plasminogen activator in a patient with acute ischemic stroke and rib fractures[J].J Nippon Med Sch,2014,81(1):43-47.
[15] Choi JC,Jang MU,Kang K,et al.Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke[J].J Am Heart Assoc,2015,4(1):e001306.
[16] Chao TF,Liu CJ,Liao JN,et al.The use of oral anticoagulants for stroke prevention in atrial fibrillation patients with history of Intra-Cranial hemorrhage[J].Circulation,2016,133(16):1540-1547.

更新日期/Last Update: 2018-10-20